41 results
8-K
EX-10.1
fbf00rijgfkzle078
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-99.1
ciogq 9viwl
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-10.1
dgju5chsxqc37gc 746
20 Mar 20
Immune Therapeutics, Inc. to Collaborate with Cytocom, Inc. to Develop Therapies for COVID-19
11:43am
S-1
puigosrpicn
14 Oct 16
IPO registration
12:00am
DRS/A
ep0jk1cqoo
14 Oct 16
Draft registration statement (amended)
12:00am